Study of Irofulven in Combination With Oxaliplatin in Patients With Advanced Solid Tumors

Mise à jour : Il y a 6 ans
Référence : NCT00374660

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The purpose of this study is to determine the maximum tolerated dose (MTD) and to investigate the efficacy, safety and pharmacokinetics of irofulven combined with oxaliplatin in patients with advanced solid tumors.


Critère d'inclusion

  • liver cancer

Liens